Skip to Content
Merck
All Photos(2)

Documents

243590

Sigma-Aldrich

Potassium perrhenate

99%

Synonym(s):

Potassium oxido(trioxo)rhenium, Potassium tetraoxorhenate(1-)

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
KReO4
CAS Number:
10466-65-6
Molecular Weight:
289.30
EC Number:
233-953-8
MDL number:
MFCD00011365
UNSPSC Code:
12352302
PubChem Substance ID:
24854622
NACRES:
NA.23

Assay

99%

form

powder

refractive index

n20/D 1.643 (lit.)

mp

550 °C (lit.)

density

4.887 g/mL at 25 °C (lit.)

SMILES string

[K+].[O-][Re](=O)(=O)=O

InChI

1S/K.4O.Re/q+1;;;;-1;

InChI key

QFKRWIFGDGKWLM-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

The reduction of KReO4 in the preparation of cyclopentadienyltricarbonylrhenium complexes has potential as a model for the syntheses of technetium and rhenium organometallic radiopharmaceuticals.

Storage Class Code

5.1B - Oxidizing hazardous materials

WGK

WGK 3

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Rhenium(VII) oxide ≥99.9% trace metals basis

Sigma-Aldrich

261955

Rhenium(VII) oxide

Spradau, T.W. Katzenellenbogen, J.A.
Organometallics, 17, 2009-2009 (1998)
Yuee Feng et al.
Inorganic chemistry, 48(23), 11058-11066 (2009-11-06)
The detailed syntheses of complexes of the form [Re(O)(X)(RNCH(2)CH(2))(2)N(Me)] (X = Me, Cl, I, R = mesityl, C(6)F(5)), 1-3, incorporating diamidoamine ancillary ligands are described. X-ray crystal structures for the complexes [Re(O)(Me)((C(6)F(5))NCH(2)CH(2))(2)N(Me)], 1a, [Re(O)(I)((C(6)F(5))N CH(2)CH(2))(2)N(Me)], 3a, and [Re(O)(I)((Mes)NCH(2))(2)N(Me)], 3b, are
J Tyler French et al.
Journal of vascular and interventional radiology : JVIR, 21(8), 1271-1279 (2010-05-19)
Minimally invasive interventional cancer therapy with drug-carrying lipid nanoparticles (ie, liposomes) via convection-enhanced delivery by an infusion pump can increase intratumoral drug concentration and retention while facilitating broad distribution throughout solid tumors. The authors investigated the utility of liposome-carrying beta-emitting
Albert Schröckeneder et al.
Inorganic chemistry, 48(24), 11608-11614 (2009-11-27)
Rhenium(V) oxo complexes of the type [ReOX(L)(2)] (1-7; X = Cl, Br) containing beta-ketiminate ligands (L = CH(3)C(O)CH(2)C(NAr)CH(3): Ar = Ph (APOH), 2-MePh (MPOH), 2,6-Me(2)Ph (DPOH), 2,6-(i)Pr(2)Ph (DiPOH)) have been prepared by reaction of [ReOX(3)(OPPh(3))(SMe(2))] (X = Cl, Br) with
Mark J Bailey et al.
Advanced healthcare materials, 1(4), 437-442 (2012-11-28)
Configuring RE(2) O(3) nanocrystals with pseudo-2D morphologies confers substantive gains in relaxivities over equivalent spherical counterparts. The most promising arises from Gd(2) O(3) whose ionic transverse and longitudinal relaxivities were as high as r(1) = 12.7 mM(-1) s(-1) and r(2)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service